Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Alpha-2b in Adjuvant Treatment of Stage III Malignant Melanoma
NCT00226408Phase 3Unknown
- Sponsor
- Dermatologic Cooperative Oncology Group
- Start
- Nov 2003
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of interferon alfa-2b in Malignant Melanoma (MM), sponsored by Dermatologic Cooperative Oncology Group. Status: unknown.
02
Drugs
interferon alfa-2b
03
Conditions
Malignant Melanoma (MM)
Beyond the preview
Go deeper on NCT00226408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00226408.